<DOC>
	<DOCNO>NCT01174849</DOCNO>
	<brief_summary>The purpose study determine whether early schedule combination three dose PHiD-CV one dose PCV13 , superior three dos either PCV13 PHiD-CV .</brief_summary>
	<brief_title>Pneumococcal Vaccines Early Combination</brief_title>
	<detailed_description>Aboriginal child Northern Territory ( NT ) high rate otitis medium cause non-capsular H. influenzae ( NCHi ) pneumococcus . Pneumococcal conjugate vaccine effectively reduce disease cause 7 serotypes . Rates non-vaccine serotype otitis medium ( OM ) , particularly 19A increase , NCHi continue major pathogen perforation . Parallels pneumonia highly probable population . Vaccines expand early age protection need . In early 2009 GSK 's pneumococcal H. influenzae protein D conjugate vaccine ( PHiD-CV ) license Australia . Compared current vaccine , 7PCV , vaccine offer protection pneumococcal serotypes 1 , 5 , 7F well NCHi ( primary pathogen OM , possibly pneumonia ) . However 2010 , new generation Wyeth 's 7PCV , PCV13 also license Australia . Compared PHiD-CV vaccine offer protection additional serotypes 3 , 6A 19A , however offer protection NCHi infection . There empirical evidence suggest either vaccine superior clinical efficacy otitis medium pneumonia high-risk child . The novel combination strategy propose trial potential provide best vaccine .</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Indigenous infant 4 6 week age Living remote community provide signed Expressions Interest participate PREVIX_COMBO trial Intend remain community baby 7 month age Eligible routine vaccination . Prior adverse reaction pneumococcal conjugate vaccine accord Australian Immunization Handbook . Gestational age &lt; 32 week</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>38 Days</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>otitis medium</keyword>
	<keyword>pneumococcal vaccine</keyword>
	<keyword>randomise control trial</keyword>
	<keyword>high-risk child</keyword>
	<keyword>indigenous</keyword>
	<keyword>Australia</keyword>
</DOC>